Literature DB >> 36159405

Bilateral hypocalcaemic cataracts due to idiopathic parathyroid insufficiency: A case report.

Yan Li1,2.   

Abstract

BACKGROUND: Hypoparathyroidism is uncommon, and cataracts secondary to hypoparathyroidism are even rarer. Herein, we report a case of bilateral cataracts following hypoparathyroidism. CASE
SUMMARY: A 27-year-old man presented to our hospital because of painless and progressive visual impairment of both eyes over two years. He was previously diagnosed with hypocalcemia but did not take calcium supplements regularly. He had no history of anterior neck thyroid surgery. After admission, the biochemical analysis indicated a serum calcium level of 1.21 mmol/L and an intact parathyroid hormone level of 0 pg/mL. Ocular examination revealed bilateral symmetrical opacity of the lens presenting as punctate opacity in the posterior subcapsular cortex together with radial opacity in the peripheral cortex (N1C2P3). Phacoemulsification with an intraocular lens was performed in both eyes sequentially. Postoperatively, the patient had a satisfactory recovery and greatly improved visual acuity.
CONCLUSION: This patient had hypocalcemia owing to idiopathic parathyroid insufficiency. Hypoparathyroidism may go unnoticed for years but with some latent clinical manifestations, such as bilateral symmetrical posterior subcapsular cataracts. This case report highlights that the cause of hypocalcemia in particularly young patients should be further investigated. Clinicians should be aware of hypoparathyroidism as a cause of bilateral cataracts. Early identification of hypoparathyroidism can save patients from further complications. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Hypocalcemia; Hypoparathyroidism; Posterior subcapsular cataract

Year:  2022        PMID: 36159405      PMCID: PMC9477687          DOI: 10.12998/wjcc.v10.i26.9378

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.534


Core Tip: Bilateral hypocalcemic cataracts secondary to hypoparathyroidism are rarely observed in ophthalmology. The main clinical manifestation is convulsions caused by hypocalcemia in the early stage. Here, we report a case of bilateral cataract with previously diagnosed hypocalcemia but for the first time to find the cause of idiopathic parathyroid insufficiency. Hypoparathyroidism may go unnoticed for years but with some latent clinical manifestations, such as bilateral symmetrical posterior subcapsular cataracts. The cause of hypocalcemia in particularly young patients should be investigated.

INTRODUCTION

Hypoparathyroidism is a disease characterized by parathyroid hormone (PTH) deficiency. In general, it can be classified based on different modalities, including congenital or acquired, genetic or nongenetic and isolated or syndromic[1]. However, the most common cause is a complication of anterior neck thyroid surgery[2]. The clinical diagnosis of hypoparathyroidism is according to the classical manifestations in patients with a low ionized or albumin-corrected blood calcium level, hyperphosphatemia and an intact PTH level that is low or not in the normal range[3]. PTH is secreted by parathyroid glands, which are maintained by serum calcium levels; thus, the serum calcium level is the first to be affected when parathyroid glands are maldeveloped or damaged during surgery. Chronic hypocalcemia can lead to the occurrence of hypocalcemic cataracts[4]. Bilateral hypocalcemic cataracts are a rare complication of hypoparathyroidism. We encountered a case of bilateral hypocalcemic cataracts due to idiopathic parathyroid insufficiency.

CASE PRESENTATION

Chief complaints

Painless and progressive visual impairment of both eyes over two years.

History of present illness

A 27-year-old man presented to our hospital because of painless and progressive visual impairment of both eyes over two years. The patient had no other positive symptoms apart from blurred vision. The patient had no other positive symptoms apart from blurred vision. The patient had no history of ocular diseases.

History of past illness

He was diagnosed with hypocalcemia when he was young but did not know exactly when and the serum calcium concentration at that time. He relied on a diet of milk or calcium-containing foods and calcium tablets to supplement his calcium levels at that time but subsequently did not take regular calcium supplements. He started to experience muscle cramps in his upper extremities, less markedly in his thighs and calves approximately ten years ago. However, he did not seek help for these symptoms until the occurrence of epilepsy. Seven years ago, he underwent cerebral surgery for epileptic seizures.

Personal and family history

The patient denied any diagnoses of personal or family history.

Physical examination

The ocular examination revealed a preoperative binocular visual acuity of 16/200, and the best-corrected visual acuity (BCVA) was not improved. The intraocular pressure in the right and left eyes was 15 mmHg and 16 mmHg, respectively. There was bilateral symmetrical opacity of the lens presenting as punctate opacity in the posterior subcapsular cortex together with radial opacity in the peripheral cortex. Fundus examination showed no pathological changes.

Laboratory examinations

The biochemical analysis indicated a serum total calcium level of 1.21 mmol/L (serum ionized calcium level 0.72 mmol/L in arterial blood gas analysis), a serum phosphorus level of 1.67 mmol/L and a serum magnesium level of 0.62 mmol/L, indicating significantly low levels of serum calcium and magnesium but high serum phosphorus. His intact PTH level was 0 pg/mL. Adrenocorticotropic hormone (ACTH), cortisol hormone at 8:00 am, thyroid-stimulating hormone, thyroid hormones (TT3, TT4, FT3, FT4), whole blood count, coagulation function, renal and liver function tests were within normal limits (Table 1). An electrocardiogram showed that there was a prolonged QT interval.
Table 1

Laboratory examination results

Parameter
Result
Reference
Calcium1.21 mmol/L2.11-2.52 mmol/L
Serum ionize calcium0.72 mmol/L1.10-1.30 mmol/L
Phosphorus1.67 mmol/L0.85-1.51 mmol/L
Magnesium0.62 mmol/L0.75-1.02 mmol/L
Parathyroid hormone (PTH)0 pg/mL12.40-76.80 pg/mL
Total triiodothyronine (TT3)1.23 ng/mL0.61-1.81 ng/mL
Total tetraiodothyronine (TT4)105.50 nmol/L58.1-140.6 nmol/L
Free triiodothyronine (FT3)3.29 pg/mL2.30-4.20 pg/mL
Free tetraiodothyronine (FT4)1.25 ng/dl0.89-1.76 ng/dl
Thyroid stmulatng hormone (TSH)2.7220 μIU/mL0.55-4.78 μIU/mL
Adrenocorticotropic hormone (ACTH)20.67 pg/mL7.20-63.30 pg/mL
Cortisol at 8:00 am13.00 μg/dLam: 4.82-19.50 μg/dL
pm: 2.47-11.90 μg/dL
Laboratory examination results

Imaging examinations

Anterior segment photography revealed punctuate opacity in the posterior subcapsular cortex together with radial opacity in the peripheral cortex (Figure 1).
Figure 1

Punctuate opacity in the posterior subcapsular together with radial opacity in the peripheral cortex (white arrow).

Punctuate opacity in the posterior subcapsular together with radial opacity in the peripheral cortex (white arrow).

FINAL DIAGNOSIS

The diagnosis of bilateral hypocalcemic cataracts was made due to idiopathic parathyroid insufficiency.

TREATMENT

The patient was intravenously administered a 100 mL infusion of 10% calcium gluconate in 1000 mL of 5% dextrose at a rate of 50 mL/h, and the serum calcium level increased from 1.21 mmol/L to 2.01 mmol/L. We performed phacoemulsification surgery with implantation of IOLs (Figure 2) (+20.0 diopters in right eye; +20.5 diopters in left eye; ZCB00, Johnson & Johnson, Santa Ana, United States) in both eyes at one-month intervals.
Figure 2

Implanted with IOL in eye after surgery.

Implanted with IOL in eye after surgery.

OUTCOME AND FOLLOW-UP

The postoperative binocular visual acuity of the BCVA was 20/20, and the patient had a satisfactory recovery with greatly improved visual acuity. He was referred to the endocrinology department for further treatment.

DISCUSSION

PTH maintains the level of ionized calcium in the blood and extracellular fluids. PTH binds to cell surface receptors in bone and kidney, thereby triggering responses that increase blood calcium. PTH also increases the renal synthesis of 1,25(OH)2D3, which then acts on intestine to augment absorption of dietary calcium, in addition to promoting calcium fluxes into the blood from bone and kidney[2]. Thyroid surgery is the most common cause of hypoparathyroidism[5]. Hypoparathyroidism also exists in the isolated form or as a syndrome related to other (usually autoimmune) disorders. Low calcium, high phosphorous, and low PTH confirmed the diagnosis of primary hypoparathyroidism[6]. Our patient had no history of any neck surgery or radiation exposure. Autoimmune adrenal involvement was also ruled out by serological tests (normal basal plasma ACTH tests) for this patient. Therefore, there were no clinical manifestations or biochemical features of Addison’s disease or mucocutaneous candidiasis, which is a type of autoimmune polyglandular syndrome[7]. Additionally, there were no characteristic symptoms of an underlying genetic disease. The biochemical analysis indicated that magnesium deficiency affects the secretion and action of PTH. When the level of magnesium in the serum decreased to 0.5 mmol/L, PTH secretion was stimulated, with severe hypomagnesemia (below 0.4 mmol/L) inhibiting PTH secretion and causing relative hypoparathyroidism[8]. The serum magnesium level in this patient was decreased but not as low as 0.4 mmol/L. Other causes of hypocalcemia were ruled out, such as metabolic disturbances, renal failure or malabsorption. The low serum calcium and magnesium but high serum phosphorus, history of chronic tetany together with bilateral cataracts and undetectable PTH fulfilled the criteria for the diagnosis of hypoparathyroidism[3]. As there were no other possible etiologies identified, his hypoparathyroidism was considered idiopathic. The association of hypoparathyroidism and cataracts was first described in 1880[9]. Hypoparathyroidism secondary to cataracts has been reported successively[5]. The pathogenesis of cataracts in hypoparathyroidism is proposed to be membrane damage due to low calcium levels in the aqueous humour[10]. Calcium plays a crucial role in triggering intracellular signaling and regulating cellular processes. Long-term hypocalcemia can cause muscle cramps, paresthesia, seizure, etc., whereas hypercalcemia can cause ectopic calcification. Calcium homeostasis is critical for the body, as calcium maintains the growth and homeostasis of the whole lens[11,12]. For cataracts secondary to hypoparathyroidism, some literature reported that low blood calcium reduced the calcium concentration around the crystalloid capsule, which suppressed the active ion transport function of the crystalloid capsule membrane and led to water and sodium storage in the lens. The following consequences were observed: crystal fiber swelling, rupture, crystal protein denaturation, decomposition and caused cataract[13,14]. Disturbed calcium homeostasis can cause lens opacity through related mechanisms, such as abnormal differentiation of lens epithelial cells (LECs) into fibrocytes, increased migration of LECs into the posterior capsule, lens protein clustering and calcium channel inactivation[15-17]. In this case, we observed that the lens presented bilateral and symmetrical punctate opacity in the posterior subcapsular cortex together with radial opacity in the peripheral cortex. We also observed iridescent opacity in the deep layer of the cortex. The patient had experienced gradual vision loss for two years, which severely worsened in the preceding year, suggesting that the function of LECs was gradually damaged. For this patient, the main reason is hypocalcemia caused by parathyroid dysfunction, which affects the calcium homeostasis of the lens. He underwent cataract surgery, and the calcium concentration of his aqueous humor was 1.03 mmol/L, comparable to that of the aqueous humor produced by filtered serum, thereby confirming the diagnosis. However, previous researchers cultured clear lenses and LECs in culture medium containing a high concentration of Ca2+ and found that lens opacity was associated with an increase in Ca2+ concentration in vitro. An abnormally high extracellular calcium concentration could damage calcium homeostasis in LECs and eventually lead to cataracts[18]. In conclusion, disruption of calcium homeostasis in either hypercalcemia or hypocalcemia leads to cataract formation. This patient was diagnosed with a calcium deficiency in childhood but did not take calcium supplements regularly. Additionally, there were no further investigations of the cause of the calcium deficiency, even when he underwent cerebral surgery for misdiagnosing epileptic seizures, until hypocalcemia led to bilateral cataracts. Recent studies reported that higher 25(OH)D levels in aqueous humor and serum were associated with cataracts[19-22]. However, to elucidate the role of the 25(OH)D level in cataracts, a larger clinical study is needed, including a control group of patients without cataracts. The diagnosis of hypoparathyroidism mainly depends on whether there are severe symptoms of hypocalcemia and parathyroid dysfunction. For this patient, it was not simply the lack of calcium but deficiency of PTH; therefore, he requires further standardized treatment and follow-up in the endocrinology department after ocular surgery. Although this patient may temporarily tolerate such a low concentration of serum calcium, there is still a risk of progressing to a more severe clinical presentation over time.

CONCLUSION

This patient had hypocalcemia owing to idiopathic parathyroid insufficiency. Hypoparathyroidism may go unnoticed for years but with some latent clinical manifestations, such as bilateral symmetrical posterior subcapsular cataracts. This case report highlights that the cause of cataracts with hypocalcemia should be further investigated, particularly in young patients. Clinicians should be aware of hypoparathyroidism as a cause of bilateral cataracts. Early identification of hypoparathyroidism can save patients from further complications.
  22 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Hypoparathyroidism.

Authors:  Rachel I Gafni; Michael T Collins
Journal:  N Engl J Med       Date:  2019-05-02       Impact factor: 91.245

Review 3.  Habitual dietary calcium intakes and calcium metabolism in healthy adults Chinese: a systematic review and meta-analysis.

Authors:  Ai-Ping Fang; Ke-Ji Li; Hao-Yu Shi; Jing-Jing He; He Li
Journal:  Asia Pac J Clin Nutr       Date:  2016-12       Impact factor: 1.662

4.  Idiopathic hypoparathyroidism with cataract and spontaneous hypocalcaemic hypercalciuria.

Authors:  K O Granström; R Hed
Journal:  Acta Med Scand       Date:  1965-10

5.  Association between serum 25-hydroxyvitamin D levels and age-related cataracts.

Authors:  Donghyun Jee; Eun Chul Kim
Journal:  J Cataract Refract Surg       Date:  2015-08       Impact factor: 3.351

Review 6.  [Update - Calcium Metabolism].

Authors:  Christof Schöfl
Journal:  Dtsch Med Wochenschr       Date:  2019-08-15       Impact factor: 0.628

7.  Serum 25-hydroxyvitamin D and Age-Related Cataract.

Authors:  Sangshin Park; Nam-Kyong Choi
Journal:  Ophthalmic Epidemiol       Date:  2017-06-28       Impact factor: 1.648

8.  Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status.

Authors:  Soma Saha; Shiva Prasad Gantyala; Sameer Aggarwal; Vishnubhatla Sreenivas; Radhika Tandon; Ravinder Goswami
Journal:  J Bone Miner Metab       Date:  2016-07-27       Impact factor: 2.626

9.  Effects of calcium on human lens epithelial cells in vitro.

Authors:  Hiroyuki Matsushima; Kouichiro Mukai; Shinichiro Yoshida; Yoshitaka Obara
Journal:  Jpn J Ophthalmol       Date:  2004 Mar-Apr       Impact factor: 2.447

Review 10.  Epidemiology and Diagnosis of Hypoparathyroidism.

Authors:  Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2016-03-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.